Company / SG&A per Share
Sunshine Biopharma Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.39
FY2025
5-year range
$0.36 / $936.66
FY2021-FY2025
Trend
-99.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2017 to $936.66 in FY2024.
Based on SEC 10-K filings.
6.39 in FY2025 with a 5-year CAGR of +222.0%.
Increased from $1.27 to $6.39 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +86.5%
- 5-Year CAGR
- +222.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 99.3% year-over-year.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.39 | -99.3% |
| FY2024 | $936.66 | +73617.8% |
| FY2023 | $1.27 | +29.1% |
| FY2022 | $0.98 | +173.9% |
| FY2021 | $0.36 | +1847.6% |
| FY2020 | $0.02 | -93.2% |
| FY2019 | $0.27 | +1356.9% |
| FY2018 | $0.02 | +1345.7% |
| FY2017 | $0.00 | -67.3% |
| FY2016 | $0.00 | -83.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026